DRI Healthcare Trust Past Earnings Performance
Past criteria checks 2/6
DRI Healthcare Trust has been growing earnings at an average annual rate of 78.5%, while the Pharmaceuticals industry saw earnings growing at 26.2% annually. Revenues have been growing at an average rate of 43.3% per year. DRI Healthcare Trust's return on equity is 16.4%, and it has net margins of 55.5%.
Key information
78.5%
Earnings growth rate
590.1%
EPS growth rate
| Pharmaceuticals Industry Growth | 23.1% |
| Revenue growth rate | 43.3% |
| Return on equity | 16.4% |
| Net Margin | 55.5% |
| Next Earnings Update | 06 May 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How DRI Healthcare Trust makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 166 | 92 | 57 | 0 |
| 30 Sep 23 | 113 | 65 | 47 | 0 |
| 30 Jun 23 | 105 | 77 | 44 | 0 |
| 31 Mar 23 | 99 | 5 | 11 | 0 |
| 31 Dec 22 | 93 | 12 | 11 | 0 |
| 30 Sep 22 | 93 | 20 | 11 | 0 |
| 30 Jun 22 | 90 | 20 | 11 | 0 |
| 31 Mar 22 | 92 | 24 | 11 | 0 |
| 31 Dec 21 | 82 | 22 | 10 | 0 |
Quality Earnings: DHT.UN has a high level of non-cash earnings.
Growing Profit Margin: DHT.UN's current net profit margins (55.5%) are higher than last year (12.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if DHT.UN's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare DHT.UN's past year earnings growth to its 5-year average.
Earnings vs Industry: DHT.UN earnings growth over the past year (695.9%) exceeded the Pharmaceuticals industry 18.4%.
Return on Equity
High ROE: DHT.UN's Return on Equity (16.4%) is considered low.